Active substance
Isopropyl alcohol
- US FDA 1
- US price lines 3
- Safety 8
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| ZURAGARD | 70% | solution · topical | ZUREX PHARMA | Over-the-counter | 26 Apr 2019 |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | FT ISOPROPYL ALCOHOL 91% | $0.05372 | per ML | 23 Sep 2026 |
| US NADAC | GNP ISOPROPYL ALCOHOL 91% | $0.05372 | per ML | 23 Sep 2026 |
| US NADAC | HM ISOPROPYL ALCOHOL 91% | $0.05372 | per ML | 23 Sep 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 20 Jan 2023 SOLUPREP — safety-related labeling change
Labeling sections changed: Adverse Reactions - US FDA 24 Jun 2021 ZURAGARD — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 12 Sep 2017 CHLORAPREP ONE-STEP SEPP — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 12 Sep 2017 CHLORAPREP SINGLE SWABSTICK — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 12 Sep 2017 CHLORAPREP TRIPLE SWABSTICK — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 7 Sep 2017 PREVANTICS MAXI SWABSTICK — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 7 Sep 2017 PREVANTICS SWAB — safety-related labeling change
Labeling sections changed: Warnings and Precautions - US FDA 7 Sep 2017 PREVANTICS SWABSTICK — safety-related labeling change
Labeling sections changed: Warnings and Precautions
Combinations containing Isopropyl alcohol
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.